COVID-19 vaccine
The autumn and winter vaccination programme, which includes the COVID-19 and flu vaccine, is available for eligible people in Northern Ireland.
Autumn and winter 2026/ 2027 programme
The vaccination programme, to help protect Northern Ireland against deadly viruses ahead of winter is now available until January 2027.
You will be offered the COVID-19 booster vaccine if you are:
- aged 75 and over
- a resident or staff member in a care home
- aged six months to 74 years and immunosuppressed
If you are eligible for vaccination against COVID-19 or flu this autumn and winter, you should make yourself aware of your own GP surgery’s or community pharmacist’s vaccination arrangements and work with them to get vaccinated.
You may be eligible for both the flu and the COVID-19 Autumn vaccines.
If you're offered both vaccines, it's safe to have them at the same time.
Where to get your COVID-19 vaccine
You can get the COVID-19 vaccine from your GP surgery if you are:
- aged 75 and over
- 18 to 74 years old and immunosuppressed
Participating community pharmacies are offering the COVID-19 vaccine to:
- care home residents
- people aged 75 and over
- those aged 18 to 74 years old who are immunosuppressed
You can get the COVID-19 vaccine from a HSC Trust clinic if you are:
- aged 75 and over
- six months to 74 years old and immunosuppressed
If you are housebound and fall within an eligible group, a HSC Trust team will be in touch to arrange your vaccination.
To book your vaccination at a Trust clinic, or find out what pharmacies are offering vaccinations, visit:
Infant programme
The COVID-19 vaccine is being offered to children aged six months to four years who are immunosuppressed, in line with the Joint Committee on Vaccination and Immunisation (JCVI) advice.
This includes, but is not limited to:
- those undergoing chemotherapy or radiotherapy, solid organ transplant recipients, bone marrow or stem cell transplant recipients
- generic disorders affecting the immune system (such as deficiencies of IRAK-4 or NEMO, complement disorder, SCID)
- those with haematological malignancy, including leukaemia and lymphoma
- those receiving immunosuppressive or immunomodulating biological therapy
- those treated with, or likely to be treated with high or moderate dose corticosteroids
- those receiving any dose of non-biological oral immune modulating drugs, such as methotrexate, azathioprine, 6-mercaptopurine or mycophenolate
- those with auto-immune diseases who may require long term immunosuppressive treatmentsFurther information about the vaccine
Some parents may receive a letter or a phone call to invite their child to an HSC Trust clinic for vaccination.
If you receive an invitation letter, it will explain how to make the appointment for your child.
A leaflet to support parents of children at serious risk from the complications of coronavirus infection is available at:
Young people aged five to 17 years
Some young people are eligible to receive the COVID-19 vaccine if they are between the ages of five and 17 and immunosuppressed.
Further information is available at:
- COVID-19 vaccination - a guide for children and young people and translations
- What to expect after your COVID-19 vaccination - advice for children and young people and translations
Pregnant or believe to be pregnant
Covid-19 vaccination is no longer routinely recommended during pregnancy.
However, you may still be eligible if you are immunosuppressed.
The vaccine can be given safely given:
- at any stage of pregnancy
- during the postpartum period
If you think you may be eligible, speak to your midwife or GP for advice.
First doses of COVID-19 vaccine
If you have never received a COVID-19 vaccine you can receive a vaccine during the autumn/ winter programme.
Further information about the vaccine
The Public Health Agency has developed a range of leaflets and a frequently asked questions section:
Types of Vaccine
There are many different types of coronavirus vaccines.
The vaccines that will be administered during the Autumn 2026/27 programme are:
- COVID-19 Spikevax® XFG (Moderna) dispersion for injection (adults)
- COVID-19 Comirnaty® XFG (Pfizer) dispersion for injection (infants, children and adolescents)
- COVID-19 Bimervax® LP.8.1 (HIPPRA) emulsion for injection (non-MRNA)
Vaccine safety
The vaccines have met strict standards of safety, quality and effectiveness set out by the independent Medicines and Healthcare products Regulatory Agency (MHRA).
More information is available at:
Coronavirus (COVID-19) vaccine research registry
The NHS COVID-19 vaccine registry allows members of the public to register their interest and be contacted to take in clinical studies.
If you are 18 years old or over and live in the UK, you can sign up to give permission for researchers to contact you about taking part in COVID-19 vaccine studies.
You are not signing up to take part in a specific health study when you use this service. You are letting researchers know you're happy for them to contact you if they think you might be suitable to take part in their studies.
More information about taking part in research and other opportunities to take part in COVID-19 research can be found at: